Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, blind, parallel controlled phase I clinical trial to evaluate the safety and preliminary immunogenicity of 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and older.
Zhang Y, Wang Y, Li G, Zhao X, Wang K, Jia C, Yang Y, Huang L, Tan J, Chen X, Leng W, Xie Z, Zhang W, Zong J, Chen K, Li Q, Jia X, Zhao D, An Y, Zhang Y. Zhang Y, et al. Among authors: zhao x, zhao d. Vaccine. 2024 Apr 19;42(11):2858-2866. doi: 10.1016/j.vaccine.2024.03.044. Epub 2024 Mar 21. Vaccine. 2024. PMID: 38519344 Clinical Trial.
[A phase Ⅲ clinical trial study on the safety and immunogenicity of ACYW135 group meningococcal conjugate vaccine inoculated in 3 month old infants].
Xie ZQ, Zhao DY, Huang HT, Gou JB, Zhang W, Yang YL, Huang LL, Wang YX, Wang X, Xu LF, Zhu T, Xia SL. Xie ZQ, et al. Among authors: zhao dy. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Sep 6;54(9):947-952. doi: 10.3760/cma.j.cn112150-20200520-00758. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 32907283 Clinical Trial. Chinese.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial.
Guo W, Duan K, Zhang Y, Yuan Z, Zhang YB, Wang Z, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang XW, Shi Z, Wang Y, Yang XQ, Zhang L, Huang L, Wang Q, Lu J, Yang YL, Guo J, Zhou W, Wan X, Wu C, Wang W, Du J, Nian X, Li XH, Huang S, Shen S, Xia S, Pan A, Yang X. Guo W, et al. Among authors: zhao d. EClinicalMedicine. 2021 Aug;38:101010. doi: 10.1016/j.eclinm.2021.101010. Epub 2021 Jul 7. EClinicalMedicine. 2021. PMID: 34250456 Free PMC article.
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang Y, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Zhang L, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Meng Z, Pan A, Yuan Z, Shen S, Guo W, Yang X. Xia S, et al. Among authors: zhao d. JAMA. 2020 Sep 8;324(10):951-960. doi: 10.1001/jama.2020.15543. JAMA. 2020. PMID: 32789505 Free PMC article. Clinical Trial.
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.
Xia S, Duan K, Zhang Y, Zeng X, Zhao D, Zhang H, Xie Z, Li X, Peng C, Zhang W, Yang Y, Chen W, Gao X, You W, Wang X, Wang Z, Shi Z, Wang Y, Yang X, Li Q, Huang L, Wang Q, Lu J, Yang Y, Guo J, Zhou W, Wan X, Wu C, Wang W, Huang S, Du J, Nian X, Deng T, Yuan Z, Shen S, Guo W, Liu J, Yang X. Xia S, et al. Among authors: zhao d. Front Immunol. 2022 Jun 24;13:898151. doi: 10.3389/fimmu.2022.898151. eCollection 2022. Front Immunol. 2022. PMID: 35812412 Free PMC article. Clinical Trial.
[Effectiveness of training on Taenia solium taeniasis and cysticercosis control knowledge among medical professionals in disease-elimination pilot areas of Henan Province].
Chen WQ, Jiang TT, Deng Y, Zhang YL, Chen X, Hong Y, Zhao DY, Lin XM, Zhang HW. Chen WQ, et al. Among authors: zhao dy. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2022 Jan 11;33(6):600-605. doi: 10.16250/j.32.1374.2021214. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2022. PMID: 35128890 Clinical Trial. Chinese.
[Epidemiological characteristics of malaria in Henan Province from 1950 to 2019].
Guo WS, Zhao DY, Zhang HW, Lu DL, Liu Y, Qian D, Yang CY, Guan Z, Zhao YL, Zhou RM, Li SH, Wang H, Deng Y, Chen WQ, Zhang YL. Guo WS, et al. Among authors: zhao dy, zhao yl. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020 Nov 20;33(1):62-65. doi: 10.16250/j.32.1374.2020150. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020. PMID: 33660476 Chinese.
[Effectiveness of health education interventions targeting taeniasis and cysticercosis among primary school students in disease-elimination pilot areas of Henan Province].
Deng Y, Jiang TT, Ji PH, Chen WQ, Zhang YL, Hong Y, Zhou RM, Yang CY, Hu YB, Lin XM, Zhao DY. Deng Y, et al. Among authors: zhao dy. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2021 Dec 15;33(6):583-589. doi: 10.16250/j.32.1374.2021215. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2021. PMID: 35128888 Chinese.
[Analysis on the sequence mutation and evolution of HBV genome in China].
Guo YH, Dou QH, Liu Q, Yang JH, Lyu YY, Feng DX, Seng MH, Zhang YY, Zhao DY. Guo YH, et al. Among authors: zhao dy. Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Aug 10;43(8):1309-1314. doi: 10.3760/cma.j.cn112338-20220411-00278. Zhonghua Liu Xing Bing Xue Za Zhi. 2022. PMID: 35981995 Chinese.
14,208 results
You have reached the last available page of results. Please see the User Guide for more information.